CES1 and metabolic dysfunction-associated steatotic liver disease: In summary, roles of TGH in NAFLD progression were studied in three independent mouse models, 16-week HFD-fed obese mice, hypolipidemic and insulin sensitive PEMT deficient mice, and hyperlipidemic and insulin resistant LDLR deficient mice to represent different phases of NAFLD accompanied with different metabolic disorders.